Free Trial

Westpark Capital's Rating of NeurAxis on 8/23/2023

On August 23, 2023, Westpark Capital updated its outlook on NeurAxis (NASDAQ:NRXS) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Westpark Capital

DateCompanyAction
9/5/2025
Microvision, Inc. stock logo
MVIS
Microvision
Reiterated Rating
9/2/2025
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
Initiated Coverage
8/29/2025
SentinelOne, Inc. stock logo
S
SentinelOne
Reiterated Rating
8/28/2025
CrowdStrike stock logo
CRWD
CrowdStrike
Reiterated Rating
8/27/2025
Okta, Inc. stock logo
OKTA
Okta
Reiterated Rating
8/27/2025
Microvision, Inc. stock logo
MVIS
Microvision
Reiterated Rating
More Ratings From Westpark Capital